1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Demographics and clinical status of the study participants
No. (Female, Male)Age (Mean) (yr)Disease Duration (mo) (Mean)UPDRS Motor Scorea (Mean)More Affected Hemibrain
Patients with PD24 (16, 8)63.3 ± 11.077.1 ± 43.720.8 ± 11.6Right 15, left 9
More affected body side (8.5 ± 4.8), less affected body side (5.1 ± 3.9)
Healthy controls24 (15, 9)64.1 ± 10.0
  • ↵a There was a significant difference in the UPDRS III motor scores between more and less affected body sides in patients with PD (P < .001).